- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04878289
Teaching Obesity Treatment Options to Adult Learners Intervention Via VA Video Connect (TOTAL)
A Non-randomized Pilot Study of the Teaching Obesity Treatment Options to Adult Learners (TOTAL) Intervention Via VA Video Connect (VVC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity is the second leading cause of death in the U.S. The treatment of obesity and its related comorbidities, including cardiovascular disease and diabetes, exceeds $150 billion annually. "Morbidly" or "severely" obese patients, defined by a body mass index (BMI) of 35 kg/m² or greater, are especially high risk for serious complications due to the metabolic and physiologic derangements that occur with severe obesity. Within the Veterans Health Administration (VA) system, nearly 600,000 patients are severely obese. These Veterans exert significant costs on the VA system, experience poorer quality of life, and have shortened lifespans. Bariatric surgery is the most effective treatment for severe obesity for weight loss, comorbidity resolution, and quality of life. Bariatric surgery is supported as a treatment option by many national societies, including those representing primary care and endocrinology. However, less than 1% of Veterans who qualify for bariatric surgery undergo it. The investigator's previous research indicates that two important barriers to obesity treatment participation are poor Veteran knowledge about the risks of obesity and obesity treatment options, and lack of Veteran motivation.
The goal of this study is to assess the feasibility and acceptability of Teaching Obesity Treatment Options to Adult Learners (TOTAL intervention) among Veterans with overweight/obesity who are not participating in MOVE! program (a Weight Management Program, supported by VA's National Center for Health Promotion and Disease Prevention (NCP). The primary outcomes will be recruitment and retention rates and acceptability of TOTAL. The secondary outcomes include MOVE! program initiation sustained MOVE! participation, obesity medication receipt, bariatric surgery referral, and weight loss 18 months post-intervention.
The investigators propose to pilot test the TOTAL intervention for up to 10 Veterans with overweight/obesity who are not currently participating in MOVE!. Once participants are consented and baseline data are obtained, participants will view the TOTAL video and participate in three one-on-one, 30-minute motivational sessions via VVC at 1-week, 6-months, and 12-months. All VVC sessions will be audio recorded. This timing was selected so Veterans would have regular interactions with the interventionist within one year of initiating the intervention. Each motivational session will be tailored to where Veterans are in the treatment initiation process. Further, the investigators will conduct 15-minute participant interviews after each motivational session to assess how the TOTAL educational video and the motivational sessions are received by Veterans using VVC. These interviews will not be audio-recorded. Lastly, participants will complete a brief post-assessment at the 18-month visit to obtain information about their obesity initiation/treatment as well as their final weight.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- William S. Middleton VA Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veteran
- BMI of 30 or greater, or
- BMI of 27 or greater with an obesity-related comorbidity
- Primary Care Physician visit within the past 12 months
Exclusion Criteria:
- Participation in the MOVE! program within the past 12 months
- Receipt of a weight-loss medication within the past 12 months
- Bariatric surgery referral within the past 12 months
- Has had bariatric surgery
- Previous stomach or small intestine surgery (at discretion of the PI)
- Severe medical condition that would preclude meaningful participation in the study
- Pregnancy or intended pregnancy during the study period
- Current breast feeding
- Cancer not in remission
- Lack of regular access to a telephone
- Lack of regular access to internet-connected device with a microphone such as a computer/laptop/tablet/smart phone
- Non-English speaking
- Hearing impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TOTAL Intervention
TOTAL video and participate in three one-on-one, 30-minute motivational sessions via VVC at 1-week, 6-months, and 12-months
|
Teaching Obesity Treatment Options to Adult Learners Educational Video with 3, 30 minute motivational sessions at 1 week, 6 months, and 12 months after viewing video
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment: Number of Participants Consented Compared to Number of Recruitment Letters Sent
Time Frame: up to 18 months
|
The ratio of consented participants to number of recruitment letters sent will measure the level of recruitment in this pilot study.
|
up to 18 months
|
Retention: Number of Participants Who Completed the Intervention Compared to Number of Participants Consented
Time Frame: up to 18 months
|
The ratio of participants who watched the video and completed all three telemedicine sessions to the number of participants consented will measure the level of retention in this pilot study.
|
up to 18 months
|
Acceptability
Time Frame: 1 week
|
Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months).
Participant perceptions will be summarized qualitatively.
|
1 week
|
Acceptability
Time Frame: 6 months
|
Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months).
Participant perceptions will be summarized qualitatively.
|
6 months
|
Acceptability
Time Frame: 12 months
|
Participants will be asked about their perceptions of watching the video and completing the motivational sessions via VVC at each session (1 week, 6 months, 12 months).
Participant perceptions will be summarized qualitatively.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants who initiated Obesity Treatment
Time Frame: up to 18 months
|
Attendance at a MOVE! visit (chart review); participation in another behavioral weight loss program (self-report), data collected at baseline, 1 week, 6 months, 12 months, 18 months
|
up to 18 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Luke M Funk, MD, MPH, FACS, William S. Middleton VA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-1043
- A539712 (Other Identifier: UW Madison)
- SMPH/SURGERY/MIS (Other Identifier: UW Madison)
- Protocol Version 12/21/2020 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on TOTAL with Motivational Telemedicine Sessions
-
The Cleveland ClinicAmerican Academy of Sleep MedicineRecruitingObstructive Sleep Apnea | Acute Decompensated Heart Failure | Motivational Enhancement | PAP AdherenceUnited States
-
The University of Tennessee, KnoxvilleNational Institute of Mental Health (NIMH)Completed
-
Medidata SolutionsMiami Research AssociatesCompletedType 2 Diabetes MellitusUnited States
-
University College, LondonBarts & The London NHS TrustCompletedCoronary Heart DiseaseUnited Kingdom
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Ministry of Health, Brazil; Conselho...Unknown
-
Mount Sinai Hospital, CanadaCrohn's and Colitis CanadaUnknownInflammatory Bowel Diseases | Crohn Disease | Medication Adherence | Ulcerative ColitisCanada
-
Eskisehir Osmangazi UniversityEskisehir City HospitalEnrolling by invitationStress Urinary IncontinenceTurkey
-
University Hospital, Strasbourg, FranceUnknown
-
Assistance Publique - Hôpitaux de ParisAgence Regionale de Sante d'Ile de FranceCompletedNursing Homes ResidentsFrance
-
Assistance Publique - Hôpitaux de ParisAgence Regionale de Sante d'Ile de FranceUnknown